Ciliary body melanoma appropriate in selected cases. Ciliary body melanoma Ciliary Body Melanoma is a type of cancer arising from the coloured part (uvea) of the eye. About 12% of uveal melanoma arise from the ciliary body. It occurs most commonly in the sixth decade. The tumour is usually diagnosed by clinical examination with a slit-lamp utilising a triple mirror contact lens. Ultrasonography and fine needle aspiration biopsy (FNAB) are also sometimes helpful in confirming the diagnosis. Enucleation (surgical removal of the eye) is the treatment of choice for large ciliary body melanomas. Small or medium sized tumors may be treated by an
The University of Illinois Eye and Ear Infirmary as the Claes Dohlman Chair in Ophthalmology, Professor of Ophthalmology at Harvard Medical School, and Senior Scientist & W. Clement Stone Scholar at The Schepens Eye Research Institute, as well as the Director, Cornea & Refractive Surgery, Massachusetts Eye & Ear Infirmary, Vice Chairman of Harvard Department of Ophthalmology, and Director of the Harvard Medical School Cornea Center for Excellence. Jennifer I. Lim: A leading authority on retina and vitreoretinal diseases, having performed more than 6,000 vitreoretinal surgeries and directed more than 50 clinical research studies and trials on age-related macular degeneration, diabetic retinopathy, macular edema and retinal vein occlusion